[Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
The difficulties of long term treatment of chronic obstructive lung disease demand knowledge and use of every reasonable therapeutic regimen. In this study effectivity and side effects of Depot-ACTH (Tetracosactid) are presented. The main indications for the use of Depot-ACTH seem to be the uneffectiveness of usual therapy and the attempt of avoiding or reducing corticosteroids. The study confirms the excellent usefulness of Depot-ACTH which did not diminish during long-term application. The side effects are rare and mostly inferior. Only allergic reactions may be serious and must be accounted for.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D002648:Child; D003366:Cosyntropin / Q000009:adverse effects / Q000627:therapeutic use*; D048909:Diabetes Complications; D004342:Drug Hypersensitivity / Q000209:etiology; D004487:Edema / Q000139:chemically induced; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D011656:Pulmonary Emphysema / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000150:complications
D003366:Cosyntropin; D000324:Adrenocorticotropic Hormone
Erfahrungen mit Depot-ACTH (Tetracosactid) bei Bronchialobstruktion